Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mario Gabelli Discloses Freshly-Made Activist Moves In Astec Industries Inc. (ASTE), Mueller Industries Inc. (MLI), And Others

Page 1 of 2

GAMCO Investors is a publicly traded asset management company established by Mario Gabelli in 1977. Gabelli, who serves as the chairman and chief executive officer of GAMCO Investors, has run the firm primarily as a one-man show. He manages just about everything: he developed the firm’s philosophy, manages the investment process, recruits the firm’s largest clients and has the last word in any of its management’s decisions. He is also considered one of the best-known money managers in the United States, while his investment methodology combines the tenets of some of the pioneers of value-oriented investing, Benjamin Graham and David Dodd, and the reputable boss of Berkshire Hathaway, Warren Buffett. Gabelli is widely-known on Wall Street for his mix of savvy stock-picking, self-promotion, and an astonishing pay package. In this article, we will be covering three of the firm’s freshly-amended 13D filings with the SEC on the following companies: Astec Industries Inc. (NASDAQ:ASTE), The Brink’s Company (NYSE:BCO) and Mueller Industries Inc. (NYSE:MLI).

Mario Gabelli

Following activist funds like Mario Gabelli’s GAMCO Investors is important because it is a very specific and focused strategy in which the investor doesn’t have to wait for catalysts to realize gains in the holding. A fund like GAMCO can simply create its own catalysts by pushing for them through negotiations with the company’s management and directors. In recent years, the average returns of activists’ hedge funds has been much higher than the returns of an average hedge fund. Furthermore, we believe do-it-yourself investors have an advantage over activist hedge fund investors because they don’t have to pay 2% of their assets and 20% of their gains every year to compensate hedge fund managers. We have found through extensive research that the top small-cap picks of hedge funds are also capable of generating high returns and built a system around this premise. In the 34 months since our small-cap strategy was launched it has returned over 123% and beaten the S&P 500 ETF (SPY) by more than 66 percentage points (read more details).

Mario Gabelli
Mario Gabelli
GAMCO Investors

In a new public filing with the SEC, GAMCO Investors disclosed an ownership stake of 2.23 million shares in Astec Industries Inc. (NASDAQ:ASTE), which represents 9.71% of the company’s outstanding common stock. This marks an increase of 317,176 shares since the asset management company’s most recent 13D filing on Astec. The shares of Astec have decreased by over 3% since the beginning of the current year, partially as a result of missing analysts’ expectations for its second quarter earnings results. The manufacturer of hot-mix asphalt facilities and soil remediation equipment posted revenue of $268 million, a decrease of 3% year-over-year. At the same time, the company posted earnings per share of $0.51, down 19% from the figure of $0.63 per share reported in the same quarter a year ago. However, Astec’s management believes that the company will be able to beat its financial results from last year’s third quarter. Within our database, Chuck Royce’s Royce & Associates is the second largest investor in Astec Industries Inc. (NASDAQ:ASTE) as of March 31 with 673,228 shares, tailing only GAMCO Investors.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!